|
US2021032576A1
|
|
Anti-viral cleaning composition, method of making and use thereof
|
|
JP2020079289A
|
|
Composition for reducing nervous system injury and methods of making and using the same
|
|
US2020197469A1
|
|
Antiviral compositions and methods
|
|
WO2020047097A1
|
|
Composition and methods for preventing or reducing the incidence of transient ischemic attacks
|
|
WO2019231848A1
|
|
Antibacterial compositions, methods of making and use thereof
|
|
US2019134151A1
|
|
Antibacterial compositions, methods of making and use thereof
|
|
US2019135873A1
|
|
Compositions and methods for treating diseases by inhibiting exosome release
|
|
US2018360829A1
|
|
Composition and methods for preventing or reducing the incidence of transient ischemic attacks
|
|
US2018265822A1
|
|
Liquid loading composition, method of making and use thereof
|
|
JP2018138592A
|
|
Composition for reducing nervous system injury and method for producing the same and use thereof
|
|
US2018066216A1
|
|
Cleaning composition, method of making and use thereof
|
|
US2017362567A1
|
|
Methods for storage and retrieval of functional mature retinal cells
|
|
CN110312549A
|
|
For treating the composition and method of disease by inhibiting the release of excretion body
|
|
US2018103885A1
|
|
Mental health assessment method and kiosk-based system for implementation
|
|
WO2018074996A1
|
|
Mental health assessment method and kiosk-based system for implementation
|
|
US2016320390A1
|
|
Compositions and methods for capturing exosomes
|
|
US2015202252A1
|
|
Treatment of ischemia
|
|
US2014134606A1
|
|
Exosome-mediated diagnosis of hepatitis virus infections and diseases
|
|
US2014155319A1
|
|
Antimicrobial compositions and methods of use thereof
|
|
US2014004181A1
|
|
Compositions and methods for exosome targeted expression
|
